Alpha Paradigm Partners, LLC Atara Biotherapeutics, Inc. Transaction History
Alpha Paradigm Partners, LLC
- $239 Million
- Q4 2022
Shares
2 transactions
Others Institutions Holding ATRA
# of Institutions
5Shares Held
2.89MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$15.8 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$8.42 Million8.12% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$37,8900.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$25,9250.0% of portfolio
-
Act Capital Management, LLC Wayne, PA900Shares$7,5780.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $795M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...